1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Health‐related quality of life in long‐term prostate cancer survivors after nerve‐sparing and non‐nerve‐sparing radical prostatectomy—Results from the multiregional PROCAS study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Nerve‐sparing (NS) surgery was developed to improve postoperative sexual and potentially urological outcomes after radical prostatectomy (RP). However, it is largely unknown how NSRP affects health‐related quality of life (HRQoL) including urinary and sexual outcomes in prostate cancer (PC) survivors 5‐10 years after diagnosis in comparison with Non‐NSRP.

          Methods

          The study population included 382 stage pT2‐T3N0M0 PC survivors 5‐10 years post diagnosis, who were identified from the multiregional Prostate Cancer Survivorship in Switzerland (PROCAS) study. Briefly, in 2017/2018, PC survivors were identified via six population‐based cancer registries based in both German‐ and French‐speaking Switzerland. HRQoL and PC‐specific symptom burden was assessed using the EORTC QLQ‐C30 and EORTC QLQ‐PR25 questionnaires. Differences in HRQoL outcomes between survivors treated with NSRP (uni‐ & bilateral) and Non‐NSRP were analyzed with multivariable linear regression adjusted for age, years since diagnosis, cancer stage, comorbidities at diagnosis, and further therapies, if appropriate. Multiple imputation was performed to minimize the bias due to missing data.

          Results

          Five to ten years after diagnosis, PC survivors treated with NSRP and Non‐NSRP reported similar symptom burden and comparable HRQoL function scores. The only significant differences were reported for sexual activity, whereas PC survivors who underwent NSRP reported statistically significant ( P = .031) higher sexual activity than those on Non‐NSRP. NSRP and Non‐NSRP reported similar scores for urinary symptoms and all other HRQoL outcomes.

          Conclusions

          Our results support nerve‐sparing techniques as an option to improve postoperative sexual, but not urinary outcomes after RP in long‐term PC survivors.

          Abstract

          Nerve‐sparing radical prostatectomy and non‐nerve‐sparing radical prostatectomy were generally associated with comparable long‐term health‐related quality of life outcomes, but nerve‐sparing radical prostatectomy was linked with significantly higher sexual activity scores than non‐nerve‐sparing radical prostatectomy. Our results support nerve‐sparing techniques as an option to improve postoperative sexual but not urinary outcomes after radical prostatectomy in long‐term prostate cancer survivors.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Interpreting the significance of changes in health-related quality-of-life scores.

          To determine the significance to patients of changes in health-related quality-of-life (HLQ) scores assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). A subjective significance questionnaire (SSQ), which asks patients about perceived changes in physical, emotional, and social functioning and in global quality of life (global QL) and the QLQ-C30 were completed by patients who received chemotherapy for either breast cancer or small-cell lung cancer (SCLC). In the SSQ, patients rated their perception of change since the last time they completed the QLQ-C30 using a 7-category scale that ranged from "much worse" through "no change" to "much better." For each category of change in the SSQ, the corresponding differences were calculated in QLQ-C30 mean scores and effect sizes were determined. For patients who indicated "no change" in the SSQ, the mean change in scores in the corresponding QLQ-C30 domains was not significantly different from 0. For patients who indicated "a little" change either for better or for worse, the mean change in scores was about 5 to 10; for "moderate" change, about 10 to 20; and for "very much" change, greater than 20. Effect sizes increased in concordance with increasing changes in SSQ ratings and QLQ-C30 scores. The significance of changes in QLQ-C30 scores can be interpreted in terms of small, moderate, or large changes in quality of life as reported by patients in the SSQ. The magnitude of these changes also can be used to calculate the sample sizes required to detect a specified change in clinical trials.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Integrating response shift into health-related quality of life research: a theoretical model.

            Patients confronted with a life-threatening or chronic disease are faced with the necessity to accommodate to their illness. An important mediator of this adaptation process is 'response shift' which involves changing internal standards, values and the conceptualization of quality of life (QOL). Integrating response shift into QOL research would allow a better understanding of how QOL is affected by changes in health status and would direct the development of reliable and valid measures for assessing changes in QOL. A theoretical model is proposed to clarify and predict changes in QOL as a result of the interaction of: (a) a catalyst, referring to changes in the respondent's health status; (b) antecedents, pertaining to stable or dispositional characteristics of the individual (e.g. personality); (c) mechanisms, encompassing behavioral, cognitive, or affective processes to accommodate the changes in health status (e.g. initiating social comparisons, reordering goals); and (d) response shift, defined as changes in the meaning of one's self-evaluation of QOL resulting from changes in internal standards, values, or conceptualization. A dynamic feedback loop aimed at maintaining or improving the perception of QOL is also postulated. This model is illustrated and the underlying assumptions are discussed. Future research directions are outlined that may further the investigation of response shift, by testing specific hypotheses and predictions about the QOL domains and the clinical and psychosocial conditions that would potentiate or prevent response shift effects.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Follow-up of Prostatectomy versus Observation for Early Prostate Cancer

              We previously found no significant differences in mortality between men who underwent surgery for localized prostate cancer and those who were treated with observation only. Uncertainty persists regarding nonfatal health outcomes and long-term mortality.
                Bookmark

                Author and article information

                Contributors
                v.arndt@Dkfz-Heidelberg.de
                Journal
                Cancer Med
                Cancer Med
                10.1002/(ISSN)2045-7634
                CAM4
                Cancer Medicine
                John Wiley and Sons Inc. (Hoboken )
                2045-7634
                10 June 2020
                August 2020
                : 9
                : 15 ( doiID: 10.1002/cam4.v9.15 )
                : 5416-5424
                Affiliations
                [ 1 ] National Institute for Cancer Epidemiology and Registration (NICER) c/o University of Zurich Zurich Switzerland
                [ 2 ] Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute University of Zurich Zurich Switzerland
                [ 3 ] Fribourg Cancer Registry Fribourg Switzerland
                [ 4 ] Health Observatory Valais Valais Cancer Registry Sion Switzerland
                [ 5 ] Cancer Registry East Switzerland St. Gallen Switzerland
                [ 6 ] Cancer Registry Graubünden and Glarus Chur Switzerland
                [ 7 ] Cancer Registry Zurich Zug, Schaffhausen and Schwyz University Hospital Zurich Zurich Switzerland
                [ 8 ] Basel Cancer Registry Cantonal Department of Health Basel Switzerland
                [ 9 ] Department of Urology Graubünden Cantonal Hospital Chur Switzerland
                [ 10 ] Department of Urology Winterthur Cantonal Hospital Winterthur Switzerland
                [ 11 ] Department of Urology St. Gallen Cantonal Hospital St. Gallen Switzerland
                [ 12 ] Unit of Cancer Survivorship Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ) Heidelberg Germany
                Author notes
                [*] [* ] Correspondence

                Volker Arndt, Unit of Cancer Survivorship (C071), Division of Clinical Epidemiology and Aging Research (C070), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

                Email: v.arndt@ 123456Dkfz-Heidelberg.de

                Author information
                https://orcid.org/0000-0002-1829-919X
                Article
                CAM43197
                10.1002/cam4.3197
                7402816
                32524704
                1387f8ab-ed99-4a4a-b5f4-9eab5d95e72c
                © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 December 2019
                : 03 May 2020
                : 06 May 2020
                Page count
                Figures: 4, Tables: 1, Pages: 9, Words: 5720
                Funding
                Funded by: Béatrice Ederer‐Weber Foundation
                Funded by: Swiss Bridge
                Categories
                Original Research
                Clinical Cancer Research
                Original Research
                Custom metadata
                2.0
                August 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.6 mode:remove_FC converted:04.08.2020

                Oncology & Radiotherapy
                health‐related quality of life,long‐term survivor,nerve‐sparing radical prostatectomy,prostate cancer,sexual outcomes,urinary outcomes

                Comments

                Comment on this article